Yes, Estarylla is a combination birth control pill. Each active tablet contains two hormones: 0.25 mg of norgestimate (a progestin) and 0.035 mg of ethinyl estradiol (a synthetic estrogen). Because it includes both a progestin and an estrogen, it falls squarely into the “combination oral contraceptive” category, as opposed to progestin-only pills sometimes called the mini-pill.
What’s in Each Pack
A standard Estarylla pack contains 28 pills designed for one full menstrual cycle. Twenty-one of those are blue active tablets, each delivering the same dose of both hormones. The remaining seven are inactive (placebo) pills that contain no hormones. You take one pill daily at the same time, cycling through the active pills first and then the placebo week, during which withdrawal bleeding typically occurs.
Because every active pill has the same hormone dose, Estarylla is classified as a monophasic pill. This distinguishes it from a related product called Tri-Estarylla, which varies the hormone dose across three phases of the cycle (a triphasic design). Both are combination pills, but the dosing pattern differs.
How It Prevents Pregnancy
The two hormones work together through multiple mechanisms. The primary one is suppressing ovulation, so your ovaries don’t release an egg. Beyond that, the hormones thicken cervical mucus, making it harder for sperm to reach the uterus, and thin the uterine lining, which reduces the chance of implantation. With typical use, about 1 out of 100 women become pregnant during the first year on Estarylla.
Other Approved Uses
The triphasic version, Tri-Estarylla, carries an additional FDA-approved indication for treating moderate acne in women 15 and older who have started menstruating. That approval only applies when the person also wants hormonal birth control. Estarylla itself is prescribed primarily for contraception, though doctors sometimes prescribe combination pills off-label for cycle regulation, menstrual cramps, or other hormonal concerns.
Cardiovascular Risks for Combination Pills
All combination oral contraceptives carry a small but real risk of serious blood clots, and Estarylla is no exception. The estrogen component is the main contributor to this risk. Clots can form in veins (deep vein thrombosis, pulmonary embolism) or arteries (stroke, heart attack). The risk is highest when you first start or restart combination pills after a break of a month or more.
Smoking dramatically increases this cardiovascular risk, especially if you’re over 35. Estarylla’s label carries a boxed warning, the FDA’s most prominent safety alert, stating that women over 35 who smoke should not use combination pills at all. Obesity and older age also raise the likelihood of clot-related complications. These risks are specific to combination pills because of the estrogen component. Progestin-only options don’t carry the same level of clot risk.
What to Do If You Miss a Pill
Consistency matters with combination pills. If you take a pill late but it’s been fewer than 24 hours, take it as soon as you remember and continue your pack on schedule. No backup contraception is needed. The same guidance applies if you’ve missed one pill entirely (24 to 48 hours late): take it right away, even if that means taking two pills in one day, and no backup method is necessary.
Missing two or more consecutive pills (48 hours or longer since your last scheduled dose) is a different situation. Take the most recent missed pill as soon as possible and discard any other missed pills. Continue the pack on your normal schedule, but use condoms or abstain for the next seven days. If those missed pills fell in the last week of active tablets (roughly days 15 through 21), skip the placebo week entirely and start a new pack right away to maintain hormone levels. If you missed pills during the first week and had unprotected sex in the previous five days, emergency contraception is worth considering.
How Estarylla Compares to Other Combination Pills
Estarylla is a generic version of the brand-name pill Ortho-Cyclen. It uses the same active ingredients at identical doses. Norgestimate, the progestin in Estarylla, is considered a newer-generation progestin with a lower tendency to cause androgenic side effects like acne or unwanted hair growth compared to older progestins. The 0.035 mg ethinyl estradiol dose is a standard amount, neither the lowest nor the highest available in combination pills on the market.
If you’re comparing Estarylla to other options, the key factors are its monophasic dosing (the same hormone level every day, which some people find simpler), its norgestimate-based formulation, and its status as a combination pill with all the benefits and risks that entails. People who cannot use estrogen due to clot risk, migraines with aura, or other contraindications would need a progestin-only alternative instead.